Low-dose dexamethasone may be preferred as a premedication protocol for patients receiving weekly docetaxel regimens due a significantly lower risk of infection compared with a higher dose regimen.
A central venous catheter self-management education program is an effective nursing intervention to promote long-term self-management of a CVC for discharged patients with cancer.
The formation of a multidisplinary taskforce and the introduction of improved products successfully reduced the rates of catheter associated urinary tract infections (CAUTI) at an oncology hospital.
Daily chlorhexidine gluconate bathing on all patients with ports and tunneled catheters decreased the rates of CLABSI on an inpatient oncology unit.
Continuous antibiotic treatment can reduce infections in young patients with acute lymphoblastic leukemia (ALL).
New research from infection control specialists found that UV robots helped reduce transmission rates of Clostridium difficile. The intervention also saved approximately $150,000 in annual direct medical costs.
Oncology nurses at a New York cancer center successfully reduced the rate of CAUTIs at their facility to zero with a novel program that gives nurses autonomy in making care decisions for patients with urinary catheters.
Men with prostate cancer on active surveillance should be informed of the risk of complications linked to repeated biopsies.
A nationwide study on patient outcomes after cancer surgeries found that while infections during hospital stays increased during a 10-year period, the death rate from those infections declined.
Knowing what cancerous conditions lead to which kinds of bacterial infections can help doctors predict which patients are likely to benefit from pretreatment with certain kinds of antibiotics.
A new mathematical model suggests that proper risk assessment for the risk of infection with cancer chemotherapy needs to evaluate both the quantity and quality of white blood cells. The model was built by Weizmann Institute mathematicians in collaboration with physicians from the Meir Medical Center in Kfar Saba and from the Hoffman-La Roche research center in Basel, Switzerland.
In a prospective, interrupted time series study, a best-practice bundle was used to address all areas of central-line care including reducing entries, having aseptic entries, and using aseptic procedures when changing components.
A comprehensive cancer center conducts a device trial comparing two connectors in an effort to improve CRBSI rates at the facility.
A new initiative launched by CDC is designed to reduce the risk of life-threatening infection in cancer patients undergoing chemotherapy.
A quadrivalent human papillomavirus (HPV) vaccine to prevent anal cancer was shown to be safe and effective in a trial of healthy men who have sex with men.
The radiation oncology department at Duke University Medical Center, Durham, North Carolina, has instituted an animal-assisted therapy (AAT) program to help outpatients reduce stress, improve mood, and decrease anxiety during their radiation therapy visit, according to a presentation during the Oncology Nursing Society 36th Annual Congress.
Oncology nurses play a vital role in patient care, including assessment, early recognition of infections, and patient and family education. Providing evidence-based care and education to severely immunocompromised patients requires knowledge about the association between viruses and diseases, the rationale of specific diagnostic tests, and current treatments.
Monitoring infection rates and introducing interventions to eliminate central line-associated bloodstream infections (CLABSIs), a serious safety concern for hospitalized oncology patients, is one way nursing care can be advanced in complex health care environments that support a culture of safety, according to a presentation at the Oncology Nursing Society 36th Annual Congress.
The effects of cancer treatment place patients at high risk for central line-associated blood stream infections (CLABSIs), which directly reflect the care provided at the time of insertion and through the lifetime of the central line. These infections are a significant cause of morbidity, mortality, and increased health care costs. These are the findings of a study presented at the Oncology Nursing Society 36th Annual Congress.
An educational intervention designed to reduce catheter-related bloodstream infections (CR-BSIs) resulted in decreased infection rates that were sustained over time, results of a quality improvement process measuring the efficacy of such interventions have shown. Incidence of CR-BSIs in hematology and oncology inpatients are a high-priority concern: severe sepsis related to these infections can result in increased costs, morbidity and mortality, and prolonged hospitalization. The data were presented at the Oncology Nursing Society 36th Annual Congress.
The CDC and the Healthcare Infection Control Practices Advisory Committee have released new guidelines to help eliminate bloodstream infections associated with intravenous catheters.
Oncology nurses are concerned about the growing number of invasive fungal infections among their cancer patients, according to a recent report.
The Seattle Cancer Care Alliance proved that aggressive infection control procedures can minimize flu cases in a patient population.
- Cholesterol-Lowering Drugs May Prevent Breast Cancer Recurrence
- Idelalisib Increases Progression-Free Survival in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
- Some Early Breast Cancer Patients Should Have Breast Conservation Instead of Mastectomy
- BBD Regimen Efficacious as First-line Therapy for Myeloma
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- Targeting AR Mutations Promising in Metastatic Prostate Cancer
- GUCS 2017: Early Immunotherapy Discontinuation in mRCC
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Myalgia-arthralgia Syndrome Associated With Taxanes in Patients with Breast Cancer
- Women Treated for DCIS Have Slightly Lower Risk for All-Cause Mortality
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|